Longer survival with pembro plus chemo in TNBC
Overall Survival Data | ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
Overall survival for oncology drugs approved for genomic indications - European Journal of Cancer
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer | British Journal of Cancer
PLOS ONE: Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
![A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7837/1/fig-2-full.png "A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery [PeerJ]")
A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery [PeerJ]
ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy - European Journal of Cancer
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer - Gynecologic Oncology
The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma - Radiotherapy and Oncology
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial - Lung Cancer
Sirtex - Overall Survival
Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience
Kaplan-Meier Plot of Overall Survival (ITT Population) | Download Scientific Diagram
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer - Journal of Geriatric Oncology
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial - The Lancet
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802) - Annals of Oncology
Kaplan-Meier curves for overall survival.
